Intraperitoneal ciprofloxacin and rifampicin versus cephradine as initial treatment of (C)APD-related peritonitis: a prospective randomized multicenter comparison (CIPPER trial)

Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Peritoneal dialysis international 2001-09, Vol.21 (5), p.480-486
Hauptverfasser:	de Fijter, CW, ter Wee, PM, Oe, LP, Verbrugh, HA
Format:	Artikel
Sprache:	eng
Schlagworte:	Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Anti-Infective Agents - administration & dosage Anti-Infective Agents - therapeutic use Antibacterial agents Antibiotics, Antitubercular - administration & dosage Antibiotics, Antitubercular - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cephalosporins - administration & dosage Cephalosporins - therapeutic use Cephradine - administration & dosage Cephradine - therapeutic use Ciprofloxacin - administration & dosage Ciprofloxacin - therapeutic use Drug Therapy, Combination Emergency and intensive care: renal failure. Dialysis management Female Humans Infusions, Parenteral Intensive care medicine Male Medical sciences Middle Aged Peritoneal Dialysis, Continuous Ambulatory - adverse effects Peritonitis - drug therapy Peritonitis - etiology Peritonitis - microbiology Pharmacology. Drug treatments Prospective Studies Rifampin - administration & dosage Rifampin - therapeutic use Staphylococcus aureus - isolation & purification Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Department of Nephrology, Free University Medical Center, Amsterdam, The Netherlands. c.w.h.defijter@olvg.nl
ISSN:	0896-8608 1718-4304
DOI:	10.1177/089686080102100509